Evidence map›Paper›PMID 31384748›Full record

ReviewVaccine: X2019

Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market.

Melissa Malhame, Edward Baker, Gian Gandhi, Andrew Jones, Philipp Kalpaxis, Robyn Iqbal, Yalda Momeni, Aurelia Nguyen

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Vaccine: X, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Melissa MalhameGavi, The Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, Grand-Saconnex 1218, Switzerland.
Edward BakerGavi, The Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, Grand-Saconnex 1218, Switzerland.
Gian GandhiUNICEF Supply Division, Oceanvej 10-12, Copenhagen 2150, Denmark.
Andrew JonesThe Bill & Melinda Gates Foundation, 500 Fifth Ave. North, Seattle, WA 98109, USA.
Philipp KalpaxisUNICEF Supply Division, Oceanvej 10-12, Copenhagen 2150, Denmark.
Robyn IqbalThe Bill & Melinda Gates Foundation, 500 Fifth Ave. North, Seattle, WA 98109, USA.
Yalda MomeniUNICEF Supply Division, Oceanvej 10-12, Copenhagen 2150, Denmark.
Aurelia NguyenGavi, The Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, Grand-Saconnex 1218, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Market shaping for health products used in lower-income countries strives to benefit public health. As a funder of vaccines, Gavi, The Vaccine Alliance (Gavi) has goals for its market shaping efforts, achieved through a strategy developed and implemented by the Gavi Secretariat, UNICEF, the World Health Organization (WHO) and the Bill & Melinda Gates Foundation (BMGF). A case-study of Gavi's fifteen-year engagement with a vaccine against diphtheria, tetanus, pertussis, hepatitis B and

Indexed as

B, billionBMGF, The Bill & Melinda Gates FoundationDALY, disability-adjusted life-yearsDTP, diphtheria tetanus pertussis vaccineDTwP, diphtheria tetanus whole-cell pertussis vaccineGavi, Gavi The Vaccine AllianceGlobal healthHepB, hepatitis B vaccineHib, haemophilus influenzae type b vaccineHMF, Healthy Market FrameworkImmunisationIPV, inactivated polio virusMarket dynamicsMarket shapingMIC, middle-income countryM, millionNRA, National Regulatory AuthorityPAHO, Pan American Health OrganizationPentavalentPRG, Procurement Reference GroupRoadmap, Supply and Procurement RoadmapSPS, Supply and Procurement StrategyUS$, United States DollarVaccinesWAP, weighted average priceWHO, World Health Organization

Identifiers

PMID31384748
PMCPMC6668221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.